On the Track of Nitrogenase
Decisive step towards understanding biological nitrogen fixation taken
Another step has been taken towards explaining the molecular mechanisms of biological fixation of nitrogen by the enzyme nitrogenase: Dr. Daniel Sippel from Prof. Dr. Oliver Einsle’s work group at the Institute of biochemistry of the University of Freiburg has shown that the iron-vanadium cofactor (FeVco) of the enzyme can release and re-bind one single sulfur ion. Previously, the Freiburg researchers were able to partly analyze the center of another nitrogenase, the iron-molybdenum cofactor (FeMoco). In order to understand its reactions better, Schiller studied a special variant of the enzyme, which contained the element vanadium instead of molybdenum, leading to a series of easily-modified chemical characteristics. When FeVco releases the sulfur ion, the binding site for nitrogen becomes available. So then two amino acids, parts of the protein, are available to supply the protons required for the reaction and keep the permuted nitrogen compound precisely in place.

The active center of the vanadium-bearing nitrogenase has a metal center from which a sulfur ion (yellow) is removed after activation, releasing a binding site for nitrogen on two of the seven iron ions (grey).
Oliver Einsle
The work group has been studying nitrogenase for a long time with the aim of making it usable for biotechnology. With it they hope to offer an alternative to industrial chemical fertilization methods such as the Haber-Bosch process, which combines nitrogen with hydrogen to make ammonia. In nature, nitrogenase is the sole enzyme to create the same reaction, however it does so without releasing surplus nitrogen compounds into the environment. Until now however the functioning of this complex, metalliferous enzyme system has not been fully explained. The information obtained by Sippel will form a new basis for the understanding of the molecular mechanisms of nitrogen fixation. This enables the researchers to understand a variety of accumulated data better and integrate them into an overall picture of the reaction of this enzyme.
Original publication
Original publication
Sippel, Daniel and Rohde, Michael and Netzer, Julia and Trncik, Christian and Gies, Jakob and Grunau, Katharina and Djurdjevic, Ivana and Decamps, Laure and Andrade, Susana L. A. and Einsle, Oliver; "A bound reaction intermediate sheds light on the mechanism of nitrogenase"; Science; 2018
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Lonza Completes Expansion of Conjugation Facility in Visp - Expansion adds development and manufacturing capacity for pre-clinical, clinical and commercial supply of bioconjugates and antibody-drug conjugates

Right under your nose: A more convenient way to diagnose Alzheimer's disease - Certain proteins in nasal discharge can indicate the onset and progression of Alzheimer's, providing an avenue for early detection
Novartis Phase III study shows ACZ885 helped substantially reduce steroid use in 45% of patients with serious form of childhood arthritis - Chronic steroid use to treat the symptoms of systemic juvenile idiopathic arthritis (SJIA) can contribute to slowed growth and delayed puberty
Novel discovery in dendritic cell signalling pathways pave the way for new therapeutic targets
Galapagos initiates Proof-of-Mechanism clinical study for candidate cachexia drug GLPG0492

A novel method to precisely deliver therapeutics inside the body - Ultrasound-controlled nanomaterials can provide on-demand, high precision delivery of proteins into human cells
Agilent Technologies Opens Global Manufacturing Facility for Life Sciences Instruments
GE Healthcare acquires bioprocessing start-up - Obtaining nanofiber-based platform purification technology for biopharmaceutical production

Analyze proteins and protein interactions with hitherto unseen performance - Life-science startup Actome announces release of first commercial products
Bayer CropScience accelerates expansion of biotech and seed business with investments of around EUR 3.5 billion through 2018

Falling Walls announces Science Breakthrough of the Year 2023 laureates - “These outstanding breakthroughs will change the face of the world and impressively prove what ingenuity, curiosity and courage can achieve”
